Healthcare

HB 4196 requires licensed medication-assisted treatment (MAT) programs in West Virginia to offer long-acting reversible contraception (LARC), such as IUDs or implants, to patients receiving methadone or suboxone for substance use treatment. This applies to all facilities providing these services under the state's licensing framework, adding it as a standard requirement to existing operational rules. The bill directly affects MAT facilities, which must now integrate LARC options into their care protocols, and patients using methadone or suboxone at these locations. It creates a concrete policy change by mandating access to these contraceptive methods without requiring additional patient steps.